These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9234821)

  • 1. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody.
    Purvén M; Frisk A; Lönnroth I; Lagergard T
    Infect Immun; 1997 Aug; 65(8):3496-9. PubMed ID: 9234821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T; Purvén M
    Infect Immun; 1993 Apr; 61(4):1589-92. PubMed ID: 8454369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.
    Wising C; Svensson LA; Ahmed HJ; Sundaeus V; Ahlman K; Jonsson IM; Mölne L; Lagergård T
    Microb Pathog; 2002 Aug; 33(2):49-62. PubMed ID: 12202104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic separation and characterization of Pasteurella haemolytica cytotoxin.
    Mosier DA; Lessley BA; Confer AW; Antone SM; Gentry MJ
    Am J Vet Res; 1986 Oct; 47(10):2233-41. PubMed ID: 3096174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of cytotoxin from the crude extract of Pseudomonas aeruginosa.
    Hayashi T; Kamio Y; Terawaki Y
    Microb Pathog; 1989 Feb; 6(2):103-12. PubMed ID: 2497292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells.
    Lagergård T; Purvén M; Frisk A
    Microb Pathog; 1993 Jun; 14(6):417-31. PubMed ID: 8412616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T; Honda T; Miwatani T
    Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a cytotoxin produced by Plesiomonas shigelloides P-1 strain.
    Okawa Y; Ohtomo Y; Tsugawa H; Matsuda Y; Kobayashi H; Tsukamoto T
    FEMS Microbiol Lett; 2004 Oct; 239(1):125-30. PubMed ID: 15451110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of protein purification methods for the enrichment of a cytotoxin from Campylobacter jejuni.
    Gatsos X; Steer DL; Junaid TA; Smith AI; Adler B; Albert MJ
    BMC Microbiol; 2012 Dec; 12():303. PubMed ID: 23259594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus ducreyi hemolysin acts as a contact cytotoxin and damages human foreskin fibroblasts in cell culture.
    Alfa MJ; DeGagne P; Totten PA
    Infect Immun; 1996 Jun; 64(6):2349-52. PubMed ID: 8675349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
    Yamaguchi H; Osaki T; Taguchi H; Kamiya S
    FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies.
    Manetti R; Massari P; Burroni D; de Bernard M; Marchini A; Olivieri R; Papini E; Montecucco C; Rappuoli R; Telford JL
    Infect Immun; 1995 Nov; 63(11):4476-80. PubMed ID: 7591088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus ducreyi, a cytotoxin-producing bacterium.
    Purvén M; Lagergård T
    Infect Immun; 1992 Mar; 60(3):1156-62. PubMed ID: 1541531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.
    Stevens MK; Latimer JL; Lumbley SR; Ward CK; Cope LD; Lagergard T; Hansen EJ
    Infect Immun; 1999 Aug; 67(8):3900-8. PubMed ID: 10417154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies reactive with all strains of Haemophilus ducreyi.
    Hansen EJ; Loftus TA
    Infect Immun; 1984 Apr; 44(1):196-8. PubMed ID: 6200440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxin from an ovine strain of Pasteurella haemolytica: characterisation studies and partial purification.
    Sutherland AD; Redmond J
    Vet Microbiol; 1986 Apr; 11(4):337-47. PubMed ID: 3727361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a Moraxella bovis cytotoxin gene.
    Angelos JA; Hess JF; George LW
    Am J Vet Res; 2001 Aug; 62(8):1222-8. PubMed ID: 11497442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.
    Borrelli S; Roggen EL; Hendriksen D; Jonasson J; Ahmed HJ; Piot P; Jansson PE; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2665-73. PubMed ID: 7790083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.